2m 2m 2m 2m 2m 2m 2m
Emergent BioSolu (EBS)
NYSE
$7.30+$0.04 (+0.48%)
Price as of Jul 24, 2026 7:34 PM EDT- $374.6MMarket Cap
- 1.26%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Emergent BioSolu (EBS)
$7.30+$0.04 (+0.48%)
EBS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.26 | ||
Change | -$0.24 (-3.20%) | ||
Open | $7.51 | ||
High | $7.65 | ||
Low | $7.24 | ||
Previous Close | $7.50 | ||
Volume | 554,005 | ||
30-Day Average Volume | 788,272 | ||
1-Week Change | -4.85% | ||
1-Month Change | -13.88% | ||
1-Year Change | 1.26% | ||
3-Year Change | -0.95% | ||
5-Year Change | -88.72% | ||
Fundamentals | |||
Shares Outstanding | 51.6M | ||
Total Assets | $1.3B | ||
Market Cap | $374.6M | ||
Enterprise Value | $787.9M | ||
Period: QTR TTM FY | |||
Revenue | $149.7M | ||
Net Income | $6.8M | ||
Free Cash Flow | -$36.2M | ||
EBIT | $13.4M | ||
EBITDA | $36.9M | ||
Net Working Capital | $488.9M | ||
EPS | $0.07 | ||
Enterprise Value/EBITDA | 21 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | 104 | ||
PEG | 1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue